The U.S. Food and Drug Administration approved Abeona Therapeutics' gene therapy for a rare skin disorder on Tuesday.

Researchers at Karolinska Institutet have identified a new mechanism where circular RNA plays a crucial role in wound healing ...

Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal ...

Following results from their new retrospective study, the researchers suggested that immediate reconstruction of the nose ...

“Callum’s was a limb-threatening injury,” Dr. Linden Head, a plastic surgeon at Kingston Health Sciences Centre who ...